Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Hydroxychloroquine for prevention of abnormal glucose in individuals at risk for type 1 diabetes
2018-000659-42Phase 2Terminated
- Sponsor
- TrialNet Coordinating Center
- Start
- Jan 2019
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial in diabetes mellitus type 1 (T1D) comparing Hydroxychloroquine with Placebo (2 arms). Started Jan 2019; status: terminated.
02
Drugs
hydroxychloroquine
03
Conditions
diabetes mellitus type 1 (T1D)
Beyond the preview
Go deeper on 2018-000659-42.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2018-000659-42.